Gastroenterology Research and Practice
Volume 2009 (2009), Article ID 387029, 9 pages
doi:10.1155/2009/387029
Research Article

Bone Health in a Nonjaundiced Population of Children with Biliary Atresia

Rachel A. Kramer,1 Babette S. Zemel,1 Jessica L. Arvay-Nezu,1 Virginia A. Stallings,1 Mary B. Leonard,2 and Barbara A. Haber1

1The Division of Gastroenterology, Hepatology & Nutrition, Children's Hospital of Philadelphia, PA 19104, USA
2The Division of Nephrology, Children's Hospital of Philadelphia, PA 19104, USA

Received 7 November 2008; Revised 31 March 2009; Accepted 30 April 2009

Academic Editor: Fabio Marra

Copyright © 2009 Rachel A. Kramer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Hadzić, M. Davenport, S. Tizzard, J. Singer, E. R. Howard, and G. Mieli-Vergani, “Long-term survival following Kasai portoenterostomy: is chronic liver disease inevitable?,” Journal of Pediatric Gastroenterology and Nutrition, vol. 37, no. 4, pp. 430–433, 2003. View at Publisher · View at Google Scholar
  2. B. L. Shneider, M. B. Brown, B. A. Haber, et al., “A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000,” The Journal of Pediatrics, vol. 148, no. 4, pp. 467–474, 2006. View at Publisher · View at Google Scholar · View at PubMed
  3. R. Idilman, N. de Maria, O. Uzunalimoglu, and D. H. van Thiel, “Hepatic osteodystrophy: a review,” Hepato-Gastroenterology, vol. 44, no. 14, pp. 574–581, 1997.
  4. E. A. Argao, B. L. Specker, and J. E. Heubi, “Bone mineral content in infants and children with chronic cholestatic liver disease,” Pediatrics, vol. 91, no. 6, pp. 1151–1154, 1993.
  5. M. Solaymani-Dodaran, T. R. Card, G. P. Aithal, and J. West, “Fracture risk in people with primary biliary cirrhosis: a population-based cohort study,” Gastroenterology, vol. 131, no. 6, pp. 1752–1757, 2006. View at Publisher · View at Google Scholar · View at PubMed
  6. S. W. van der Merwe, D. Attfield, J. Fevery, and J. B. van den Bogaerde, “Hepatic osteodystrophy: the influence of liver disease and portal hypertension on cytokine activation,” Medical Hypotheses, vol. 54, no. 5, pp. 842–845, 2000. View at Publisher · View at Google Scholar · View at PubMed
  7. S. Ormarsdóttir, O. Ljunggren, H. Mallmin, K. Michaëlsson, and L. Lööf, “Increased rate of bone loss at the femoral neck in patients with chronic liver disease,” European Journal of Gastroenterology and Hepatology, vol. 14, no. 1, pp. 43–48, 2002. View at Publisher · View at Google Scholar
  8. A. E. Rutherford and D. S. Pratt, “Cholestasis and cholestatic syndromes,” Current Opinion in Gastroenterology, vol. 22, no. 3, pp. 209–214, 2006. View at Publisher · View at Google Scholar · View at PubMed
  9. S. A. Abrams and K. O. O'Brien, “Calcium and bone mineral metabolism in children with chronic illnesses,” Annual Review of Nutrition, vol. 24, pp. 13–32, 2004. View at Publisher · View at Google Scholar · View at PubMed
  10. G. I. Baroncelli, S. Bertelloni, F. Sodini, and G. Saggese, “Osteoporosis in children and adolescents etiology and management,” Pediatric Drugs, vol. 7, no. 5, pp. 295–323, 2005. View at Publisher · View at Google Scholar
  11. J. A. Clowes, B. L. Riggs, and S. Khosla, “The role of the immune system in the pathophysiology of osteoporosis,” Immunological Reviews, vol. 208, pp. 207–227, 2005. View at Publisher · View at Google Scholar · View at PubMed
  12. E. Daci, S. van Cromphaut, and R. Bouillon, “Mechanisms influencing bone metabolism in chronic illness,” Hormone Research, vol. 58, pp. 44–51, 2002. View at Publisher · View at Google Scholar
  13. C. F. J. Munns and C. T. Cowell, “Prevention and treatment of osteoporosis in chronically ill children,” Journal of Musculoskeletal Neuronal Interactions, vol. 5, no. 3, pp. 262–272, 2005.
  14. P. Frei, M. Fried, V. Hungerbuhler, C. Rammert, V. Rousson, and G. A. Kullak-Ublick, “Analysis of risk factors for low bone mineral density in inflammatory bowel disease,” Digestion, vol. 73, no. 1, pp. 40–46, 2006. View at Publisher · View at Google Scholar · View at PubMed
  15. S. A. Bartram, R. T. Peaston, D. J. Rawlings, D. Walshaw, R. M. Francis, and N. P. Thompson, “Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease,” World Journal of Gastroenterology, vol. 12, no. 35, pp. 5680–5686, 2006.
  16. F. Walther, C. Fusch, M. Radke, S. Beckert, and A. Findeisen, “Osteoporosis in pediatric patients suffering from chronic inflammatory bowel disease with and without steroid treatment,” Journal of Pediatric Gastroenterology and Nutrition, vol. 43, no. 1, pp. 42–51, 2006. View at Publisher · View at Google Scholar · View at PubMed
  17. A. Gupta, S. Paski, R. Issenman, and C. Webber, “Lumbar spine bone mineral density at diagnosis and during follow-up in children with IBD,” Journal of Clinical Densitometry, vol. 7, no. 3, pp. 290–295, 2004. View at Publisher · View at Google Scholar
  18. F. A. Sylvester, N. Wyzga, J. S. Hyams, et al., “Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 13, no. 1, pp. 42–50, 2007. View at Publisher · View at Google Scholar · View at PubMed
  19. M. C. Lodder, Z. de Jong, P. J. Kostense, et al., “Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density,” Annals of the Rheumatic Diseases, vol. 63, no. 12, pp. 1576–1580, 2004. View at Publisher · View at Google Scholar · View at PubMed
  20. G. Lien, A. M. Selvaag, B. Flatø, et al., “A two-year prospective controlled study of bone mass and bone turnover in children with early juvenile idiopathic arthritis,” Arthritis and Rheumatism, vol. 52, no. 3, pp. 833–840, 2005. View at Publisher · View at Google Scholar · View at PubMed
  21. C. Lee, O. Almagor, D. D. Dunlop, et al., “Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids,” Rheumatology, vol. 45, no. 1, pp. 53–60, 2006. View at Publisher · View at Google Scholar · View at PubMed
  22. K. Uchida, M. Inoue, K. Otake, et al., “The significance of serum hepatocyte growth factor levels in planning follow-up of postoperative jaundice-free patients with biliary atresia,” Journal of Pediatric Surgery, vol. 41, no. 10, pp. 1657–1662, 2006. View at Publisher · View at Google Scholar · View at PubMed
  23. J. M. Tanner, Growth at Adolescence, Blackwell Scientific, Oxford, UK, 2nd edition, 1962.
  24. C. L. Ogden, R. J. Kuczmarski, K. M. Flegal, et al., “Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version,” Pediatrics, vol. 109, no. 1, pp. 45–60, 2002. View at Publisher · View at Google Scholar
  25. J. M. Tanner, R. H. Whitehouse, N. Cameron, W. A. Marshall, M. J. R. Healy, and H. Goldstein, Assessment of Skeletal Maturity and Prediction of Adult Height (TW2 Method), Academic Press, London, UK, 1983.
  26. M. B. Leonard, H. I. Feldman, B. S. Zemel, J. A. Berlin, E. M. Barden, and V. A. Stallings, “Evaluation of low density spine software for the assessment of bone mineral density in children,” Journal of Bone and Mineral Research, vol. 13, no. 11, pp. 1687–1690, 1998. View at Publisher · View at Google Scholar · View at PubMed
  27. M. B. Leonard, K. J. Propert, B. S. Zemel, V. A. Stallings, and H. I. Feldman, “Discrepancies in pediatric bone mineral density reference data: potential for misdiagnosis of osteopenia,” The Journal of Pediatrics, vol. 135, no. 2, part 1, pp. 182–188, 1999.
  28. J. M. Burnham, J. Shults, E. Semeao, et al., “Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition,” Journal of Bone and Mineral Research, vol. 19, no. 12, pp. 1961–1968, 2004. View at Publisher · View at Google Scholar · View at PubMed
  29. J. E. Heubi, B. W. Hollis, and R. C. Tsang, “Bone disease in chronic childhood cholestasis. II. Better absorption of 25-OH vitamin D than vitamin D in extrahepatic biliary atresia,” Pediatric Research, vol. 27, no. 1, pp. 26–31, 1990.
  30. K. Ohshima, Y. Kubo, and N. Samejima, “Bone mineral analysis and X-ray examination of the bone in patients with biliary atresia,” Japanese Journal of Surgery, vol. 20, no. 5, pp. 537–544, 1990. View at Publisher · View at Google Scholar
  31. V. Chongsrisawat, P. Ruttanamongkol, T. Chaiwatanarat, B. Chandrakamol, and Y. Poovorawan, “Bone density and 25-hydroxyvitamin D level in extrahepatic biliary atresia,” Pediatric Surgery International, vol. 17, no. 8, pp. 604–608, 2001. View at Publisher · View at Google Scholar · View at PubMed
  32. W. S. Andrews, C. M. L. Pau, H. P. Chase, L. C. Foley, and J. R. Lilly, “Fat soluble vitamin deficiency in biliary atresia,” Journal of Pediatric Surgery, vol. 16, no. 3, pp. 284–290, 1981.
  33. M. B. Leonard and B. S. Zemel, “Current concepts in pediatric bone disease,” Pediatric Clinics of North America, vol. 49, no. 1, pp. 143–173, 2002. View at Publisher · View at Google Scholar
  34. J. C. Bucuvalas, J. E. Heubi, B. L. Specker, D. J. Gregg, A. L. Yergey, and N. E. Vieira, “Calcium absorption in bone disease associated with chronic cholestasis during childhood,” Hepatology, vol. 12, no. 5, pp. 1200–1205, 1990. View at Publisher · View at Google Scholar
  35. H. A. Bischoff-Ferrari, E. Giovannucci, W. C. Willett, T. Dietrich, and B. Dawson-Hughes, “Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes,” American Journal of Clinical Nutrition, vol. 84, no. 1, pp. 18–28, 2006.
  36. F. L. Weng, J. Shults, M. B. Leonard, V. A. Stallings, and B. S. Zemel, “Risk factors for low serum 25-hydroxyvitamin D concentrations in otherwise healthy children and adolescents,” American Journal of Clinical Nutrition, vol. 86, no. 1, pp. 150–158, 2007.
  37. A. Toki, T. Todani, Y. Watanabe, et al., “Bone mineral analysis in patients with biliary atresia after successful Kasai procedure,” Tohoku Journal of Experimental Medicine, vol. 181, no. 1, pp. 213–216, 1997.
  38. R. I. Gafni and J. Baron, “Overdiagnosis of osteoporosis in children due to misinterpretation of Dual-energy X-ray absorptiometry (DEXA),” The Journal of Pediatrics, vol. 144, no. 2, pp. 253–257, 2004. View at Publisher · View at Google Scholar · View at PubMed
  39. L. K. Bachrach, “Assessing bone health in children: who to test and what does it mean?,” Pediatric Endocrinology Reviews, vol. 2, pp. 332–336, 2005.
  40. C. E. Neville, P. J. Robson, L. J. Murray, et al., “The effect of nutrient intake on bone mineral status in young adults: the Northern Ireland young hearts project,” Calcified Tissue International, vol. 70, no. 2, pp. 89–98, 2002. View at Publisher · View at Google Scholar · View at PubMed
  41. C. M. Gordon, L. K. Bachrach, T. O. Carpenter, G. Karsenty, and F. Rauch, “Bone health in children and adolescents: a symposium at the annual meeting of the Pediatric Academic Societies/Lawson Wilkins Pediatric Endocrine Society, May 2003,” Current Problems in Pediatric and Adolescent Health Care, vol. 34, no. 6, pp. 226–242, 2004. View at Publisher · View at Google Scholar · View at PubMed
  42. R. P. Heaney, S. Abrams, B. Dawson-Hughes, et al., “Peak bone mass,” Osteoporosis International, vol. 11, no. 12, pp. 985–1009, 2000. View at Publisher · View at Google Scholar
  43. S. C. Manolagas and R. L. Jilka, “Bone marrow, cytokines, and bone remodeling: emerging insights into the pathophysiology of osteoporosis,” The New England Journal of Medicine, vol. 332, no. 5, pp. 305–311, 1995. View at Publisher · View at Google Scholar
  44. A. Rusińska and D. Chlebna-Sokół, “Evaluation of interleukin-1 and -6 in the etiopathogenesis of idiopathic osteoporosis and osteopenia in children,” Archivum Immunologiae et Therapiae Experimentalis, vol. 53, no. 3, pp. 257–265, 2005.